These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20556786)

  • 1. DNA-repair pathway inhibitors for the treatment of ovarian cancer.
    Martinek I; Haldar K; Gaitskell K; Bryant A; Nicum S; Kehoe S; Morrison J
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007929. PubMed ID: 20556786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.
    Wiggans AJ; Cass GK; Bryant A; Lawrie TA; Morrison J
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD007929. PubMed ID: 25991068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.
    Tattersall A; Ryan N; Wiggans AJ; Rogozińska E; Morrison J
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD007929. PubMed ID: 35170751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis inhibitors for the treatment of ovarian cancer.
    Gaitskell K; Martinek I; Bryant A; Kehoe S; Nicum S; Morrison J
    Cochrane Database Syst Rev; 2011 Sep; (9):CD007930. PubMed ID: 21901715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor blockers for the treatment of ovarian cancer.
    Morrison J; Thoma C; Goodall RJ; Lyons TJ; Gaitskell K; Wiggans AJ; Bryant A
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007927. PubMed ID: 30321910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
    Morrison J; Haldar K; Kehoe S; Lawrie TA
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD005343. PubMed ID: 22895947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor blockers for the treatment of ovarian cancer.
    Haldar K; Gaitskell K; Bryant A; Nicum S; Kehoe S; Morrison J
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007927. PubMed ID: 21975775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interval debulking surgery for advanced epithelial ovarian cancer.
    Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P; Bryant A
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD006014. PubMed ID: 26747297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval debulking surgery for advanced epithelial ovarian cancer.
    Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P; Bryant A
    Cochrane Database Syst Rev; 2013 Apr; 4(4):CD006014. PubMed ID: 23633332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interval debulking surgery for advanced epithelial ovarian cancer.
    Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P; Bryant A
    Cochrane Database Syst Rev; 2010 Oct; (10):CD006014. PubMed ID: 20927744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
    Morrison J; Swanton A; Collins S; Kehoe S
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005343. PubMed ID: 17943850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
    Coleridge SL; Bryant A; Kehoe S; Morrison J
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD005343. PubMed ID: 33543776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
    Coleridge SL; Bryant A; Lyons TJ; Goodall RJ; Kehoe S; Morrison J
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Winter-Roach BA; Kitchener HC; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance.
    Wang L; Wang Q; Xu Y; Cui M; Han L
    Curr Drug Targets; 2020; 21(2):167-178. PubMed ID: 31553293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Lawrie TA; Winter-Roach BA; Heus P; Kitchener HC
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004706. PubMed ID: 26676202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interval debulking surgery for advanced epithelial ovarian cancer.
    Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006014. PubMed ID: 19370622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interval debulking surgery for advanced epithelial ovarian cancer.
    Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006014. PubMed ID: 19160263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.